A Critique of SAINT II: wishful thinking, dashed hopes, and the future of neuroprotection for acute stroke.
Savitz
Sean I
SI
Department of Neurology, University of Texas, Houston Medical School, Houston, Texas, USA. sean.i.savitz@uth.tmc.edu
Schäbitz
Wolf-Rüdiger
WR
D000208:Acute Disease; D001557:Benzenesulfonates / Q000627:therapeutic use*; D002986:Clinical Trials as Topic / Q000592:standards*; D006801:Humans; D018696:Neuroprotective Agents / Q000627:therapeutic use*; D020521:Stroke / Q000188:drug therapy*; D017211:Treatment Failure
D001557:Benzenesulfonates; D018696:Neuroprotective Agents; C120851:disufenton sodium